A legacy of trust. A future of care. Established in 2008, Kowa Pharmaceuticals America, Inc., is committed to continuing the development and commercialization of safe, effective healthcare solutions primarily in the area of cardiometabolic diseases. As we expand and evolve, we do so by maintaining ethical and professional standards—and it all starts with people. By empowering our employees to live this mission, we can create a healthier vision for the future.
Kowa Mission Is To
• Develop and commercialize safe, effective, and high-quality pharmaceutical products at a reasonable cost
• Be patient focused and provide the highest level of patient support and service
• Conduct all business with honesty, professionalism, and integrity
• Maximize internal talent by hiring, training, and retaining the very best employees
Kowa Pharmaceuticals America, Inc., headquartered in Montgomery, Alabama, is focused primarily in the area of cardiometabolic diseases. Established in 2008, KPA focuses its efforts on the successful commercialization of its current and near-term portfolio of pharmaceutical products and business development activities.